COVID-19 is impacting all of us and challenging previous ways of working. This is a period of disruption. In this new reality, RWE will take a more prominent role to improve patient outcomes, meet stakeholder needs, and answer business questions. Join Pharmaceutical Executive®, IQVIA, and leading healthcare industry thought leaders to better understand the role and importance of RWE during and after COVID-19, what it means for your business today, and how you can plan for tomorrow with confidence.
- Murray Aitken, Executive Director, IQVIA Institute of Human Data Science
- Markus Gores, PhD, Vice President of Thought Leadership EMEA, IQVIA